Mydayis®
ADHD
Approved/CommercialDeveloped for Shire/Takeda
Key Facts
Indication
ADHD
Phase
Approved/Commercial
Status
Developed for Shire/Takeda
Company
About Supernus Pharmaceuticals
Supernus Pharmaceuticals is a commercial-stage biopharma leader in CNS disorders, leveraging deep expertise in drug delivery and product development to build a diversified portfolio. The company has demonstrated consistent growth, earning recognition on lists like Forbes' America's Best Small Companies and Fortune's 100 Fastest Growing Companies. With a foundation of marketed products generating revenue, Supernus is strategically advancing mid- and late-stage pipeline candidates while maintaining a patient-centric culture and operational excellence.
View full company profileTherapeutic Areas
Other ADHD Drugs
| Drug | Company | Phase |
|---|---|---|
| Vyvanse (lisdexamfetamine) | Takeda Pharmaceutical | Commercial |
| Centanafadine | Otsuka Holdings | Phase 3 |
| TCM-based formulation | Regencell Bioscience | Preclinical |
| Methylphenidate ER | Lupin Limited | Approved |
| Adderall XR® | Supernus Pharmaceuticals | Approved/Commercial |
| Intuniv® | Supernus Pharmaceuticals | Approved/Commercial |